依达拉奉联合吡拉西坦治疗大面积脑梗死疗效观察  

Efficacy of edaravone piracetam in the treatment of massive cerebral infarction

作　　者：王升[1] 

机构地区：[1]河南省南阳市第一人民医院神经内一科,473010

出　　处：《中国实用医刊》2015年第13期75-77,共3页Chinese Journal of Practical Medicine

摘　　要：目的探讨使用依达拉奉联合吡拉西坦治疗大面积脑梗死的治疗效果。方法选取南阳市第一人民医院在2010年1月至2013年9月收治的84例大面积脑梗死患者，随机将其分为对照组和观察组，每组42例。对照组采用脑复康联合血栓通滴丸治疗，观察组采用依达拉奉联合吡拉西坦治疗，比较两组患者的治疗效果。结果观察组痊愈21例，有效15例，总有效率为85．71％；对照组痊愈15例，有效10例，总有效率为59．52％。结论依达拉奉联合吡拉西坦治疗大面积脑梗死疗效显著，值得在临床上推广。Objective To investigate the effect of edaravone piracetam in treatment of massive cerebral infarction. Methods Eighty four patients with massive cerebral .infarction admitted in hospital from January 2010 to Sep-tember 2013 were selected and randomly divided into two groups. Forty two patients in the control group were conducted brain rehabilitation therapy combined Xueshuantong dropping, and another forty two ca- ses in the observation group accepted edaravone piracetam treatment. The effects of two groups of patients were compared. Results Twenty one cases totally recovered in the observation group, fifteen cases of patients effectively recovered, and the total effective rate was 85.71%. Fifteen cases totally recov- ered in the control group, ten cases effectively recovered, and the total effective rate was 59.52%. Conclusions Edaravone piracetam are significantly effective in the treatment of massive cerebral, so it is worthy of being promoted in clinical practice.

关 键 词：大面积脑梗塞 依达拉奉联合吡拉西坦 脑复康联合血栓通滴丸 

分 类 号：R743.33[医药卫生—神经病学与精神病学]